ARCHIVES

Are Cancer Drugs Getting Better? FDA’s Richard Pazdur Says “Yes”

This article is from The Cancer Letter archive.

Vol. 40 No. 07 | February 14, 2014

Download PDF Visit The Full Archive

Related Articles

Abstract Of Papers Presented By Breast Cancer Task Force

September 24, 1976

Anamorelin Increases Body Mass In Two Global Phase III Trials

October 31, 2014

NCI May Seek Cuts In R01s, P01s If Congress Approves Rescission

January 30, 1981

Also NCI prostate SPOREs plan biospecimen bank.

December 10, 2004

NCI CTEP Approved Trials For the Month of July

July 26, 2013

NIH Advisors Urge Stronger Peer Review, Clinical Center Renewal

May 20, 1994